Suchergebnisse - "Hodgkinson, Victoria"

PubPharm (28)

1

A real-world study of Nusinersen effects in adults with spinal muscular atrophy type 2 and 3

enthalten in: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques | 2024

von Côté, I. | Hodgkinson, V. | Nury, M. | +2

2

Chronic glucocorticoid management in neuromuscular disease : A survey of neuromuscular neurologists

enthalten in: Muscle & nerve | 2024

von Stepanian, L. | Laughlin, R. | Bacher, C. | +5

3

A Study on the Incidence and Prevalence of 5q Spinal Muscular Atrophy in Canada Using Multiple Data Sources

enthalten in: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques | 2024

von Price, T. | Hodgkinson, V. | Westbury, G. | +7

4

Gold Coast criteria expand clinical trial eligibility in amyotrophic lateral sclerosis

enthalten in: Muscle & nerve | 2022

von Jewett, G. | Khayambashi, S. | Frost, G. | +5

CommentIn: Muscle Nerve. 2022 Oct;66(4):377-379. - PMID 35822531

5

Response to Provincial Governments' Decisions Regarding Monitoring for Adults with Spinal Muscular Atrophy

enthalten in: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques | 2021

von Hodgkinson, V. | Chapman, K. | Izenberg, A. | +12

6

A Canadian Adult Spinal Muscular Atrophy Outcome Measures Toolkit : Results of a National Consensus using a Modified Delphi Method

enthalten in: Journal of neuromuscular diseases | 2021

von Slayter, J. | Hodgkinson, V. | Lounsberry, J. | +17

7

A National Spinal Muscular Atrophy Registry for Real-World Evidence

enthalten in: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques | 2020

von Hodgkinson, V. | Oskoui, M. | Lounsberry, J. | +47

8

Clinically Meaningful Difference for the Infant Gastroesophageal Questionnaire Revised version (I-GERQ-R) : A Quantitative Synthesis

enthalten in: Patient related outcome measures | 2020

von Smith, A. | Fawkes, N. | Kotze, H. | +2

9

Two placebo-controlled crossover studies in healthy subjects to evaluate gastric acid neutralization by an alginate-antacid formulation (Gaviscon Double Action)

enthalten in: Drug development and industrial pharmacy | 2019

von Wilkinson, J. | Abd-Elaziz, K. | den Daas, I. | +5

10

Randomized clinical trial : a double-blind, placebo-controlled study to assess the clinical efficacy and safety of alginate-antacid (Gaviscon Double Action) chewable tablets in patients with gastro-oesophageal reflux disease

enthalten in: European journal of gastroenterology & hepatology | 2019

von Wilkinson, J. | Wade, A. | Thomas, S. | +3